ArticleThe oncologist2026

Prolonged response to pembrolizumab in BRAFV600E microsatellite stable metastatic colorectal cancer following an increase in tumor mutational burden.

Yu-Hsuen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.